JD Health InternationalJDHIF 90 3-Year ROIIC % is 18.08 as of Dec. 2025, which is 265% above its 10-year median of 4.96. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $10.42. The stock has 1 warning sign investors should review. Among 617 Healthcare Providers & Services companies, JD Health International ranks better than 71.8% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
JD Health International's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 18.08%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for JD Health International's 3-Year ROIIC % or its related term are showing as below:
JDHIF's 3-Year ROIIC % is ranked better than 71.8% of 617
companies
in the Healthcare Providers & Services industry
Industry Median: 3.01
vs JDHIF: 18.08
JD Health International (OTCPK:JDHIF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
JD Health International 3-Year ROIIC % Related Terms
JD Health International 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International 3-Year ROIIC % Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where JD Health International's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
JD Health International (JDHIF) has a 3-Year ROIIC % of 18.08 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on JD Health International and its competitors. This is 265% above median its historical median of 4.96. According to the industry distribution chart, JD Health International ranks #174 out of 617 companies in the Healthcare Providers & Services industry, placing it in the top 28.2%.
Is JD Health International's 3-Year ROIIC % too high?
JD Health International's current 3-Year ROIIC % of 18.08 is 265% above median its 10-year median of 4.96. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.01. JD Health International's value of 18.08 is 500.7% above this industry median. Based on the distribution chart, JD Health International ranks #174 out of 617 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's 3-Year ROIIC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #174 out of 617 companies for 3-Year ROIIC %. This puts JD Health International in the upper half of its industry. The industry median 3-Year ROIIC % is 3.01. JD Health International's value of 18.08 is 500.7% above this benchmark. While the company's 10-year median is 4.96 vs. the industry median of 3.01, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.01, based on 617 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current 3-Year ROIIC % of 18.08 is 500.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current 3-Year ROIIC % is 18.08, which is 265% above median its own 10-year median of 4.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current 3-Year ROIIC % of 18.08. The stock's GF Value™ is $10.42, compared to a current price of $5.85 — trading 43.9% below its estimated fair value. The current 3-Year ROIIC % is 18.08, which is 265% above median its 10-year median of 4.96 and 500.7% above the Healthcare Providers & Services industry median of 3.01. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For JD Health International (JDHIF), the current 3-Year ROIIC % is 18.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (JDHIF) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of $5.85 is trading 43.9% below its estimated GF Value™ of $10.42.
Key valuation signals for JDHIF:
3-Year ROIIC %: 18.08 (265% above median its 10-year median of 4.96)
GF Value™: $10.42 vs. price of $5.85 (43.9% below fair value)
Industry Position: 500.7% above the Healthcare Providers & Services median (#174 of 617)
No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score
Get the complete analysis for JDHIF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JDHIF has been successfully added to your 
